wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q33788308-4E3A64A0-F3DC-4F59-ADE6-86E44467AD59
Q33788308-4E3A64A0-F3DC-4F59-ADE6-86E44467AD59
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33788308-4E3A64A0-F3DC-4F59-ADE6-86E44467AD59
Telavancin: a novel semisynthetic lipoglycopeptide agent to counter the challenge of resistant Gram-positive pathogens
P2860
Q33788308-4E3A64A0-F3DC-4F59-ADE6-86E44467AD59
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33788308-4E3A64A0-F3DC-4F59-ADE6-86E44467AD59
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d60dc54bb4e4e24551bbcf7f8852f119aebfe53d
P2860
Comparative in vitro activities and postantibiotic effects of the oxazolidinone compounds eperezolid (PNU-100592) and linezolid (PNU-100766) versus vancomycin against Staphylococcus aureus, coagulase-negative staphylococci, Enterococcus faecalis, an